SMS Pharmaceuticals Limited has received CEP approval for Ibuprofen from the European Directorate for the Quality of Medicines & HealthCare (EDQM).

Commenting on this, P. Vamsi Krishna, Executive Director - SMS Pharmaceuticals Limited said, "We are pleased to receive the CEP approval for Ibuprofen by the EDQM. This we believe is a testimony of the company's quality standards and capabilities. With this, the company can start selling Ibuprofen in the European markets. The company will continue to explore avenues to further grow the revenue from Ibuprofen.

The company's growth trajectory is expected to accelerate further, in the upcoming quarters underpinned by the recovery in the key products and further geographic expansion for Ibuprofen and other products. The Company is committed to meeting the highest quality standards and is further committed to be fully compliant with the GMP regulations at all our manufacturing facilities."